TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive CAM Therapies Should Be Held to Conventional Standards and Congress Should Toughen Dietary Supplements Act, IOM Panel Says. January 21, 2005
TCL Archive Klausner Reaffirms NCI’s “No. 1 Priority” Is Funding investigator-Initiated Research September 13, 1996
